Home > Insider Trading > Filing (0001209191-16-107657)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1077183	Neogenomics Inc	NEO	Services-Testing Laboratories (8734)	742897368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1518733	M Douglas Oort Van	12701 Commonwealth Drive Suite 9 Fort Myers FL 33913	Chairman And Ceo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-03-08	1,000,000	$0.80	2,125,000	No	4	M	Direct
Common Stock	Disposition	2016-03-08	290,000	$7.19	1,835,000	No	4	S	Direct
Common Stock	Disposition	2016-03-09	160,000	$6.93	1,675,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	StockOption (Right to Buy)	Disposition	2016-03-08	1,000,000	$0.80	1,000,000	$0.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-12-31	2016-03-15	No	4	X	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	187,500	Indirect	Conundrum Capital Partners

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$1.71	2013-02-14	2017-02-14	800,000	800,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2017-02-14	800,000	800,000	Direct

Footnotes

Includes 125,000 shares of restricted stock that the Board of Directors approved and granted on April 15, 2014. The terms of the award call for the stock to vest on the third anniversary of the grant date as long as Mr. Van Oort is still an employee of the Company. This was disclosed in our Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on July 29, 2014.
Common stock was sold on March 8, 2016 and March 9, 2016 and proceeds from the sale were used as payment of the exercise price and tax liability associated with the exercise of the 1,000,000 stock options expiring on March 15, 2016. The total shares disposed of were 450,000 shares and 550,000 were retained.
Conundrum Capital Partners, LLC is a limited liability partnership 50% owned by Mr. VanOort. Mr.VanOort is a managing partner of Conundrum Capital Partners, LLC.
On March 19, 2009, Mr. Van Oort was granted options to purchase 1,000,000 shares. These options are being exercised as they expire on March 15, 2016.
On February 14, 2012, Mr. VanOort was granted options to purchase 800,000 shares. These shares vest equally over each of the first four anniversaries of the grant date.